Page last updated: 2024-10-27

glimepiride and Parkinsonian Disorders

glimepiride has been researched along with Parkinsonian Disorders in 1 studies

glimepiride: structure given in first source

Parkinsonian Disorders: A group of disorders which feature impaired motor control characterized by bradykinesia, MUSCLE RIGIDITY; TREMOR; and postural instability. Parkinsonian diseases are generally divided into primary parkinsonism (see PARKINSON DISEASE), secondary parkinsonism (see PARKINSON DISEASE, SECONDARY) and inherited forms. These conditions are associated with dysfunction of dopaminergic or closely related motor integration neuronal pathways in the BASAL GANGLIA.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ishola, IO1
Akataobi, OE1
Alade, AA1
Adeyemi, OO1

Other Studies

1 other study available for glimepiride and Parkinsonian Disorders

ArticleYear
Glimepiride prevents paraquat-induced Parkinsonism in mice: involvement of oxidative stress and neuroinflammation.
    Fundamental & clinical pharmacology, 2019, Volume: 33, Issue:3

    Topics: Animals; Antioxidants; Cytokines; Dose-Response Relationship, Drug; Inflammation; Lipid Peroxidation

2019